The US FDA has approved Journavx, a new pain reliever without the risks for addiction or overdose linked to drugs like Vicodin and OxyContin.

Exposure to cold in the Netherlands and to heat in Spain appears to be associated with more psychiatric symptoms among adolescents.

Heat-related deaths are expected to climb throughout Europe this century due to climate change, according to study findings.

Patients colonized with AMR pathogens showed high risk for infection with the same pathogen for up to 2 years, indicating a time window for decolonization interventions.

Mepolizumab reduces asthma exacerbations among real-world patients with severe asthma and an eosinophilic phenotype.

Distribution of prescribed opioid analgesics is lower in majority non-White vs majority White communities across all levels of socioeconomic deprivation.

Adult and pediatric patients who received 2023-2024 influenza vaccines exhibited reduced risk for influenza-associated encounters across care settings.